Trial Profile
A randomised study to evaluate Everolimus and CNI (Calcineurin inhibitor) reduction vs Tacrolimus in patients with renal transplantation
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 03 Mar 2016
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Ciclosporin; Mycophenolate mofetil; Tacrolimus
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 03 Mar 2016 New trial record